Risk for GI Bleed Increased With Hemodialysis Versus Peritoneal Dialysis
THURSDAY, Jan. 19, 2023 -- The risk for newly diagnosed gastrointestinal (GI) bleeding is increased for patients undergoing hemodialysis (HD) versus peritoneal dialysis (PD), according to a study published online Jan. 2 in Scientific... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 19, 2023 Category: Pharmaceuticals Source Type: news

Peritonitis Tied to Cardiovascular Mortality in Peritoneal Dialysis Population
TUESDAY, Dec. 27, 2022 -- For patients receiving peritoneal dialysis, peritonitis is associated with an increased risk for cardiovascular mortality, according to a study published in the November issue of Kidney International Reports. Using data... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 27, 2022 Category: Pharmaceuticals Source Type: news

Decrease Noted in Peritoneal Dialysis-Linked Peritonitis Rates
MONDAY, Sept. 26, 2022 -- Peritoneal dialysis (PD)-associated peritonitis rates have decreased over time, according to a study published online Sept. 12 in the American Journal of Kidney Diseases. Eric W. Young, M.D., from Arbor Research... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 26, 2022 Category: Pharmaceuticals Source Type: news

Peritoneal Dialysis Less Costly for Medicare Than Hemodialysis
WEDNESDAY, Aug. 24, 2022 -- Peritoneal dialysis (PD) costs Medicare less than hemodialysis, according to a study published online Aug. 18 in the Journal of the American Society of Nephrology. Jennifer M. Kaplan, M.D., from Baylor College of Medicine... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 24, 2022 Category: Pharmaceuticals Source Type: news

InFocus: Diagnosing Peritoneal Dialysis Complications in the ED
No abstract available (Source: Emergency Medicine News)
Source: Emergency Medicine News - February 1, 2022 Category: Emergency Medicine Tags: InFocus Source Type: news

Diabetes Plus Low HDL-C Boost Peritonitis During Dialysis Diabetes Plus Low HDL-C Boost Peritonitis During Dialysis
An observational, multicenter Chinese study showed that diabetes plus low HDL-C significantly links with a nearly doubled peritonitis rate in patients on peritoneal dialysis.First Look (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - January 18, 2022 Category: Neurology Tags: Diabetes & Endocrinology News Source Type: news

No benefit of peritoneal dialysis over haemodialysis for uninsured ESKD patients in the USA
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2021 Category: Drugs & Pharmacology Source Type: news

What Are the Advantages and Disadvantages of Different Renal Replacement Therapies?
Discussion Kidneys are amazing in that they filter the blood, eliminate toxins, balance fluids and electrolytes plus have a lot of reserve to do the job they need to do even when injured. Therefore, depending on the problem, chronic renal disease (CRD) often allows time before renal replacement therapy (RRT) is needed. RRT currently is dialysis (peritoneal or hemodialysis) or renal transplant. In general, the patient’s own kidneys do the best job for them but there is always a balance between the problems of CRD and its management, versus the potentially improved renal function with RRT. RRT itself though has a diffe...
Source: PediatricEducation.org - September 13, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Critical tetramine poisoning after sea snail ingestion in a patient on peritoneal dialysis: a case report - Yeo IH, Lim JH.
Tetramine in gastropods can cause poisoning symptoms with various side effects. Most of these symptoms are mild and spontaneously resolved due to the rapid excretion of tetramine through the kidneys; however, patients with kidney dysfunction can present se... (Source: SafetyLit)
Source: SafetyLit - July 5, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

LSU Health study finds psychosocial factors may drive peritoneal dialysis patient dropout
(Louisiana State University Health Sciences Center) A retrospective study conducted by LSU Health New Orleans reports that contrary to previous research, most patients who drop out of peritoneal dialysis may do so for psychosocial reasons. The findings are published inThe American Journal of the Medical Sciences. The paper inspired a companion editorial. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 19, 2021 Category: International Medicine & Public Health Source Type: news

U.S. Nephrology Trainees Doubt Skill in Home Hemodialysis
FRIDAY, Nov. 20, 2020 -- U.S. nephrology trainees report moderate and low confidence for peritoneal dialysis (PD) and home hemodialysis (HHD), respectively, according to a study published online Nov. 16 in the American Journal of Kidney... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 20, 2020 Category: Pharmaceuticals Source Type: news

Increasing Peritoneal Dialysis Initiation Worldwide Increasing Peritoneal Dialysis Initiation Worldwide
Could an assisted peritoneal dialysis program help increase utilization?Nephrology Dialysis Transplantation (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - November 18, 2020 Category: Intensive Care Tags: Nephrology Journal Article Source Type: news

U.S. FDA Approves New Pediatric Formulation of SIRTURO ® (bedaquiline) as Part of Combination Therapy to Treat Children with Pulmonary Multidrug-Resistant Tuberculosis
NEW BRUNSWICK, NJ, May 27, 2020 — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted approval for a new pediatric formulation of SIRTURO® (bedaquiline). SIRTURO® is now indicated for use as part of combination therapy in the treatment of adult and pediatric patients (5 years and older and weighing at least 15 kg) with pulmonary multidrug-resistant tuberculosis (MDR‑TB). In the U.S., the medicine should be reserved for use when an effective treatment regimen cannot otherwise be provided. This indication received accelerated appro...
Source: Johnson and Johnson - May 27, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Coronavirus Disease 2019 (COVID-19): Special Considerations for Patients on Home Dialysis
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 4/16/2020. This web page provides guidance on risk and patient management for patients on home dialysis during the COVID-19 pandemic. Facilities should ensure that home dialysis patients have all the supplies they need to continue their dialysis treatments and should work with suppliers to understand if shortages are anticipated in items such as peritoneal dialysis fluid. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 16, 2020 Category: International Medicine & Public Health Source Type: news

CloudCath closes $12M for catheter-based treatment monitoring platform
The company ' s initial product is designed for end stage renal disease patients receiving peritoneal dialysis in their homes. (Source: mobihealthnews)
Source: mobihealthnews - February 13, 2020 Category: Information Technology Source Type: news